A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)
Conditions: Dyslipidemias; Non-Alcoholic Fatty Liver Disease Interventions: Drug: LY3885125; Drug: Placebo Sponsor: Eli Lilly and Company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials
Positive Phase 1/2 Clinical Trial Results of Genethon ’s Gene Therapy for Crigler-Najjar Syndrome, a Rare Liver Disease, Published in The New England Journal of Medicine
PARIS--(BUSINESS WIRE) August 22, 2023 --Genethon, a pioneer and leader in gene therapy research and development for rare genetic diseases, announced today positive Phase 1/2 clinical trial results of its gene therapy, GNT-0003, for Crigler-Najjar... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - August 22, 2023 Category: Pharmaceuticals Source Type: clinical trials
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease
Conditions: Liver Disease Chronic; End Stage Liver DIsease; Cirrhosis; Cirrhosis, Liver; Advanced Cirrhosis Intervention: Behavioral: LiverPAL Sponsor: Massachusetts General Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2023 Category: Research Source Type: clinical trials
